This is an application for renewal of the Research Scientist Award by Mary Jeanne Kreek, MD. Narcotic addiction continues to be a major problem in the United States, with heroin abuse at some time identified in around 2 million persons, and regular use of heroin in over one-half million persons. The second largest risk group for the development of AIDS and for presence of infection with the human immunodeficiency virus (HIV) are parenteral drug abusers, primarily heroin addicts. This group may be the primary source of spread of HIV to the heterosexual population and to infants. At this time approximately 75,000 former heroin addicts are in chronic methadone maintenance treatment; however waiting lists for treatment continue to grow. Cocaine abuse including abuse by smoking the new free-base """"""""crack"""""""" form, the most rapidly increasing drug abuse problem, with around 6 million people in the U.S. using cocaine regularly. Although several studies on treatment of cocaine abuse are in progress, to date there is no effective treatment generally available. Knowledge as to the biological basis of narcotic addition, although increasing, remains incomplete; even less is known about the biological basis of cocaine dependency in humans. The overall objectives of our proposed studies, which will involve both clinical and experimental research, as well as new technique development, will continue to focus on: 1) studies of disposition, metabolism, and drug interactions of addictive drugs and drugs used in the management of addictions; 2) studies of the physiological and pharmacological effects of opioids, opioid antagonists, and cocaine on neuroendocrine, gastroenterological, hepatic and immunological function, with emphasis on elucidating the biological correlates of treatment of addictions, the roles of endogenous opioids in normal physiology and in pathological states, and the possible relationships of defined physiological effects of the metabolic basis of addictive disease; and 3) surveillance of patients in chronic pharmacological treatment of narcotic addiction, and also cocaine dependency, coupled with studies of the natural history, during treatment, of co-existing major medical problems, especially alcoholic liver disease, hepatitis-B, hepatitis delta, and HIV infections, all of which are major public health problems.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Scientist Award (K05)
Project #
5K05DA000049-15
Application #
3075344
Study Section
Drug Abuse Clinical and Behavioral Research Review Committee (DACB)
Project Start
1978-02-01
Project End
1993-01-31
Budget Start
1992-02-01
Budget End
1993-01-31
Support Year
15
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Rockefeller University
Department
Type
Other Domestic Higher Education
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Zhang, Y; Brownstein, A J; Buonora, M et al. (2015) Self administration of oxycodone alters synaptic plasticity gene expression in the hippocampus differentially in male adolescent and adult mice. Neuroscience 285:34-46
Schlussman, S D; Buonora, M; Brownstein, A J et al. (2013) Regional mRNA expression of GABAergic receptor subunits in brains of C57BL/6J and 129P3/J mice: strain and heroin effects. Brain Res 1523:49-58
Lane, D A; Reed, B; Kreek, M J et al. (2011) Differential glutamate AMPA-receptor plasticity in subpopulations of VTA neurons in the presence or absence of residual cocaine: implications for the development of addiction. Neuropharmacology 61:1129-40
Nielsen, David A; Ji, Fei; Yuferov, Vadim et al. (2010) Genome-wide association study identifies genes that may contribute to risk for developing heroin addiction. Psychiatr Genet 20:207-14
Kreek, M J; Schlussman, S D; Reed, B et al. (2009) Bidirectional translational research: Progress in understanding addictive diseases. Neuropharmacology 56 Suppl 1:32-43
Nielsen, David A; Yuferov, Vadim; Hamon, Sara et al. (2009) Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts. Neuropsychopharmacology 34:867-73
Lahita, Robert G; Schaefer, Robert A; Bradlow, H Leon et al. (2009) Clues to understanding the oxidation of estradiol in humans: effects of acute infectious hepatitis, autoimmune hepatitis, and chronic liver disease. Ann N Y Acad Sci 1155:242-51
Levran, O; Londono, D; O'Hara, K et al. (2009) Heroin addiction in African Americans: a hypothesis-driven association study. Genes Brain Behav 8:531-40
Maiya, Rajani; Zhou, Yan; Norris, Erin H et al. (2009) Tissue plasminogen activator modulates the cellular and behavioral response to cocaine. Proc Natl Acad Sci U S A 106:1983-8
Levran, Orna; O'Hara, Kimberly; Peles, Einat et al. (2008) ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence. Hum Mol Genet 17:2219-27

Showing the most recent 10 out of 105 publications